Scientific Content

Early Intervention and Disease Modification in Atopic Dermatitis

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

Saudi Health Promotion and Prevention Guideline for Diabetes Mellitus

Guidelines for RSV prevention with Nirsevimab

Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract infections in infants and young children. Nirsevimab is a long-acting monoclonal antibody that provides passive immunization against RSV, offering protection throughout the RSV season with a single dose

RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation

This video explains WEQAYA's strategy on Nirsevimab Implementation

An easy guide to use Nirsevimab

Pre-Ramadan assessment and Risk calculation for people with diabetes who want to fast during Ramadan

Type II Summit 2025

Video Showcasing the Type II Summit 2025

Type 2 Inflammation and Prurigo Nodularis

World Epilepsy Day Podcast Ep. 3